monocytogenes</i> strains, such as live-attenuated double-deleted <i>Listeria</i> (LADD), lacking two key virulence factors, Δ<i>actA</i> and Δ<i>inlB</i>, have been used safely in clinical trials and showed promising anti-tumor activity. This evidence concerns the gene ACTA1 and neoplasm.